A comprehensive overview of treatment options available for patients with prostate cancer and factors that influence treatment decisions.
Case #1: A 66-Year-Old-Man with Prostate Cancer
Initial Presentation (June 2022)
Clinical workup
Initial Treatment (starting July 2022)
12-week Follow-up Notes (October 2022)
Study: Lower PCSM is seen with radical prostatectomy vs other modalities
November 14th 2023"This large registry study with data from varied practice settings, incorporating the most commonly used treatment modalities, provides useful data on the long-term mortality outcomes," writes Badar M. Mian, MD.
Comparing Leuprolide Formulations in Advanced Prostate Cancer
November 13th 2023In the third article of the series, Melanie McGilloway, NP-C, an advanced practice provider at Genesis Urology in San Diego, discusses the various formulations of leuprolide, a gonadotropin-releasing hormone (GnRH) agonist used for treating advanced prostate cancer.